Lyell Immunopharma was joined by new corporate backers Lilly Asia Ventures Biosciences and Alexandria Venture Investments to bring Sonoma’s series A round to $70m.

The insurer has put $54m into a corporate venturing arm called SwissHealth Ventures to target digital health startups.

Three Pulsalys businesses in healthcare and consumer feature in the first intake, run in partnership with local incubator Les Premières Aura.

The Biohaven spinoff has picked up $60m in its series A round as it expects to increase its headcount tenfold.

Sinopharm Capital chipped in for a series B round aimed at expanding MEDx's precision healthcare operation.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

JD.com’s healthcare spinoff has filed for an initial public offering after raising more than $1.9bn in equity funding from investors including Hillhouse Capital and Citic Capital.

UT Southwestern-founded Taysha Gene Therapies surpassed its goal after underwriters bought additional shares.

Tencent has led a round worth hundreds of millions of dollars for New Ruipeng, which is now valued at $4.4bn and also backed by Boehringer Ingelheim and Country Garden.

Roche has injected funding into Palladio, creators of a drug for autosomal dominant polycystic kidney disease.